Mf. Lebodic et al., IMMUNOHISTOCHEMICAL STUDY OF 100 PANCREATIC TUMORS IN 28 PATIENTS WITH MULTIPLE ENDOCRINE NEOPLASIA, TYPE-I, The American journal of surgical pathology, 20(11), 1996, pp. 1378-1384
One hundred pancreatic tumors ranging in size from 0.3 to 7 cm were st
udied in 28 patients (17 male and 11 female patients, mean age 35 year
s) with multiple endocrine neoplasia, type I. An immunohistochemical s
tudy was performed on deparaffinized sections using the following anti
bodies: neuron-specific enolase, chromogranin A or synaptophysin, insu
lin, glucagon, somatostatin, pancreatic polypeptide (PP), vasoactive i
ntestinal peptide (VIP), gastrin, adrenocorticotropic hormone, alpha-s
ubunit of human chorionic gonadotropin, gonadotropin-releasing factor,
serotonin, and calcitonin. Among the 100 tumors (all multiple), seven
were unclassified, 10 were plurihormonal, and 83 produced a predomina
nt hormonal secretion (with 50-90% of the same cell type), including 3
7 ''A-cell tumors'' (glucagon). 27 ''B-cell tumors'' (insulin), 11 PP-
cell tumors, one G-cell tumor (gastrin) and one vasoactive intestinal
peptide (VIP)-cell tumor. These multiple tumors had a different predom
inant hormonal secretion in the same patient in 23 of the 28 cases. Th
ere was a preferential association of A-cell turner and B-cell tumor,
Hyperplasia of the islets of Langerhans was not detected in adjacent p
ancreas. Nesidioblastosis was observed in 30% of cases.